INDIAN authorities have given approval for a late-stage clinical trial of a protein-based Covid-19 vaccine candidate developed by Sanofi SA and GlaxoSmithKline Plc, the drugmakers said.
France's Sanofi and Britain's GSK in May kicked off global trials to include more than 35,000 adults to test the shot. They hope to get approvals by the end of 2021 after early-stage results showed the vaccine produces a robust immune response.
The Indian arm of the studies will enrol roughly 3,000 adults between the ages of 18 years and 55 years, according to India's clinical trial registry.
ALSO READ: India expects first doses of Covid-19 vaccine through COVAX by August
The assessment is expected to run for a year and the first enrolment in India is shown to have been made on Tuesday (6).
The Indian drug regulator did not immediately respond to a request for comment.
"As the virus continues to evolve, we are anticipating what will be needed in the coming months and years, and accordingly, have adapted our vaccine development program," Annapurna Das, Sanofi's India head, said in a statement.
India on Friday (9) reported 43,393 new Covid-19 cases in the last 24 hours, according to data from the health ministry, with active cases at 458,727. Experts have warned that actual figures could be higher than those reported.
The highly contagious Delta variant of the coronavirus, first identified in the South Asian country, is also hurting global recovery plans as the death toll surpassed four million worldwide.
GSK and Sanofi's vaccine candidate uses the same technology as one of Sanofi's seasonal influenza vaccines. It will be coupled with an adjuvant, a substance that acts as a booster to the shot, made by GSK.
Sanofi also plans to test the vaccine as a booster, regardless of which shot a person may have received first.
The companies said study participants can get vaccinated with an approved Covid-19 shot during the study if they wish to.
Army personnel stand amid the rubble following an explosion inside the police headquarters at Kohat in Pakistan's Khyber Pakhtunkhwa province on September 18, 2026. An explosion at a historic police headquarters in northern Pakistan on September 18 killed at least eight people and wounded 35 more, officials said, with the country's president swiftly blaming a militant group. Getty Images
Mourners read the holy Quran while sitting around the grave of a paramilitary personnel of the Frontier Corps (FC) who was killed during the Afghanistan-Pakistan border clashes, in Kohat on October 17, 2025. A ceasefire along the frontier between Afghanistan and Pakistan was holding on October 16, officials on both sides said, after dozens of troops and civilians were killed in cross-border clashes.Getty Images
Katrina Kaif reacts to postpartum beauty comments, reveals her 'skin became sensitive' and 'feeling best matters more'